Interferon ?1 (human fibroblast protein moiety)
Transverse Myelitis
Beth Israel Deaconess Medical Centerprotein_peptidePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Transverse Myelitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ELCUBRAGISTAT Abide Therapeutics | Phase 1 | CC |
Same molecule, other indications
Interferon ?1 (human fibroblast protein moiety) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →